U.S. Markets closed

Merck's Oncology Business Will Help It Crush the Bear Market

·3 min read
Merck's Oncology Business Will Help It Crush the Bear Market

The pharma giant has also performed well in the stock market this year, and it could continue on its upward trajectory for many years. Let's consider why Merck is an excellent cancer-related stock to buy now. Merck's most important product in its oncology lineup is Keytruda.